Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease

We report the results of a long-term follow-up of subjects in a phase 1 study of AAV2-hAADC (adeno-associated virus type 2–human aromatic L-amino acid decarboxylase) gene therapy for the treatment of Parkinson's disease (PD). Ten patients with moderately advanced PD received bilateral putaminal...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hum Gene Ther
Main Authors: Mittermeyer, Gabriele, Christine, Chadwick W., Rosenbluth, Kathryn H., Baker, Suzanne L., Starr, Philip, Larson, Paul, Kaplan, Paul L., Forsayeth, John, Aminoff, Michael J., Bankiewicz, Krystof S.
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2012
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4530392/
https://ncbi.nlm.nih.gov/pubmed/22424171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hum.2011.220
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados